Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Bill & Melinda Gates Foundation

Q3 2023 · 13F-HR

Bill & Melinda Gates Foundationholdings as filed

Filed 2023-11-13 · accession 0000898432-23-000781

$83.9M
Reported value
9
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
45258D105IMCRIMMUNCORE HLDGS PLC$29.9M35.7%576,923CommonSOLE
09075V102BNTXBIONTECH SE$16.2M19.3%148,674CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$14.6M17.4%1,559,142CommonSOLE
N2451R105CVACCUREVAC N V$11.1M13.2%1,625,943CommonSOLE
30223G102EXAIEUREXSCIENTIA$7.2M8.57%1,590,909CommonSOLE
G5709L109LUMIRADX LTD$3.4M4.09%14,285,714CommonSOLE
124155102BFLYBUTTERFLY NETWORK INC$1.2M1.42%1,011,003CommonSOLE
04965G109BCELUSDATRECA INC$237,2870.28%912,642CommonSOLE
03236M200AMYRIS INC$17,5440.02%292,398CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.